14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
Pay equity continues to be a complex and evolving issue for employers. Although the Equal Employment...
Read More >
On February 11, 2019, President Trump signed an Executive Order (E.O. 13859) launching the American ...
Read More >
On July 6, 2020, the U.S. Supreme Court granted in part and denied in part the U.S. Army Corps of En...
Read More >
The role of HR in corporate compliance programs, is often underestimated. If your company has a cult...
Read More >
As we recently wrote here, Uber and Postmates (and two of their drivers) to file an eleventh-hour la...
Read More >
On November 6, 2019, the Internal Revenue Service (IRS) released Notice 2019-59, which sets forth th...
Read More >